Evidence map›Paper›PMID 35336154›Full record

ArticleMicroorganisms2022

Plasmid-Mediated Quinolone Resistance (PMQR) in Two Clinical Strains of

Xenia Vázquez, Javier Fernández, Silvia Hernáez, Rosaura Rodicio, Maria Rosario Rodicio

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Comparative genomic and ecological insights intoFrontiers in microbiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Quinolone Antibiotics: Resistance and Therapy.Infection and drug resistance · 2023
    Review
  9. Genomic Analysis of Two MDR Isolates ofAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xenia VázquezDepartamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo (UO), 33006 Oviedo, Spain.
Javier FernándezGrupo de Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.ORCID 0000-0002-7081-0936
Silvia HernáezServicio de Microbiología, Hospital Universitario de Álava (HUA), 01009 Álava, Spain.
Rosaura RodicioGrupo de Microbiología Traslacional, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Maria Rosario RodicioDepartamento de Biología Funcional, Área de Microbiología, Universidad de Oviedo (UO), 33006 Oviedo, Spain.ORCID 0000-0002-3402-2908
Universidad de Oviedo · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Universitario Araba · ES

Funding

"Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad", Spain, cofunded by European Regional Development Fund of the European Union: a way to making Europe. FIS PI17/00474
6 · The paper itself

Abstract

Non-typhoid serovars of

Indexed as

ColEIncQ1phylogenetic analysisPMQRqnrS1Salmonella enterica serovar CorvallisST1541whole genome sequencing

Identifiers

PMID35336154
PMCPMC8953408
OpenAlexW4221083976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.